Research Article

Efficacy of Statin Therapy Related to Baseline Renal Function in Patients with Rheumatic Heart Disease Undergoing Cardiac Surgery

Table 1

Baseline characteristic of RHD patients with significant associations with eGFR.

CharacteristicOverall CrCl 80 ml/min
CrCl 50–79 ml/min
value

Age, y
 Mean (SD)56.2 (13.5)57.7 (13.4)53.0 (13.2)0.89
 Minimum, maximum19, 9119, 9122, 75
Female sex, %59.646.786.40.01
BMI0.03
 Mean (SD)22.8 (4.4)23.1 (4.7)22.0 (3.7)
 Minimum, maximum14, 3914.0, 39.016.0, 34.0
LVEF
 Mean (SD)60.4 (10.1)59.7 (10.9)62.0 (8.0)0.76
 Minimum, maximum29.0, 75.029.0, 75.045.0, 75.0
ESR0.77
 Mean (SD)17.8 (12.5)16.1 (11.7)18.6 (16.4)
 Minimum, maximum3, 772.0, 60.03.0, 77.0
Antistreptolysin “O”0.95
 Mean (SD)83.6 (70.2)78.7 (73.0)94.8 (63.5)
 Minimum, maximum11, 36511, 36517, 261
BNP
 Mean (SD)1808.8 (2213.6)1873.1 (2300.6)1674.2 (2038.3)0.63
 Minimum, maximum7.2, 9236.07.2, 9036.021.7, 6778.0
Hb
 Mean (SD)132.5 (22.1)136.8 (21.7)123.5 (20.4)0.01
 Minimum, maximum65.0, 259.069.0, 259.065.0, 155.0
PLT
 Mean (SD)201.8 (62.2)203.4 (60.8)198.4 (65.7)0.66
 Minimum, maximum70.0, 495.070.0, 495.0116.0, 444.0
CRP
 Mean (SD)10.7 (13.4)10.7 (13.2)10.7 (14.1)0.99
 Minimum, maximum2, 762.0, 71.02, 76
ALT
 Mean (SD)26.5 (21.8)26.6 (19.1)26.3 (26.7)0.94
 Minimum, maximum8.0, 173.08.0, 173.09.0, 66.0
AST
 Mean (SD)28.1 (23.6)28.9 (26.5)26.1 (15.8)0.52
 Minimum, maximum6.0, 189.06.0, 189.08.0, 69.0
NYHA class III/IV, %38.40%37.50%39.20%0.67
Hypertension, %27.226.129.50.69
Diabetes mellitus, %8.88.79.10.47
Medications
 ASA, %47.844.848.80.32
 ARB, %33.133.332.10.54
 ACEI, %28.129.227.50.44
 ß-blocker, %46.747.744.30.17
 Warfarin, %4.74.54.90.74
 Clopidogrel, %13.914.613.20.58

BMI indicates body mass index; ESR, erythrocyte sedimentation rate; LVEF, left ventricular ejection; BNP, brain natriuretic peptide; PLT, platelet; CRP, C reactive protein; ALT, alanine aminotransferase; AST, glutamate oxaloacetate transaminase; Hb, hemoglobin; NYHA class, New York Heart Association functional class; ARB, angiotensin receptor blocker; ACEI, angiotensin-converting enzyme inhibitor.